Mark D. Argentine

Learn More
To optimize a controlled release (CR) matrix formulation with two goals: (1) effectively deliver a prodrug to a preferred absorption region of the upper GI tract, and (2) afford a PK profile similar to a “reference” CR formulation. A pharmacoscintigraphic clinical study was conducted using a flexible formulation design space. A six-arm, three-prototype(More)
  • 1